Mirador Capital Partners LP Pacific Biosciences Of California, Inc. Transaction History
Mirador Capital Partners LP
- $546 Million
- Q3 2024
A detailed history of Mirador Capital Partners LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 223,212 shares of PACB stock, worth $395,085. This represents 0.07% of its overall portfolio holdings.
Number of Shares
223,212
Previous 61,394
263.57%
Holding current value
$395,085
Previous $84,000
351.19%
% of portfolio
0.07%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding PACB
# of Institutions
255Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$59.1 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$41.8 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$41.4 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$35.9 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$31.2 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $398M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...